Literature DB >> 8404013

Malignant pleural mesothelioma.

H I Pass1, H W Pogrebniak.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8404013     DOI： 10.1016/0011-3840(93)90029-g

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN： 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  3 in total

1.  A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction.

Authors:  H W Pass; B K Temeck; K Kranda; S M Steinberg; H I Pass
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

Review 2.  Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.

Authors:  Siyamek Neragi-Miandoab
Journal:  Support Care Cancer       Date:  2008-02-08       Impact factor: 3.603

3.  Expression of cancer-associated molecules in malignant mesothelioma.

Authors:  Ben Davidson
Journal:  Biomark Insights       Date:  2007-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.